超敏C反应蛋白与阵发性房颤射频消融术后早期复发的关系

doi:10.12047/j.cjap.5601.2017.125

中国应用生理学杂志 ›› 2017, Vol. 33 ›› Issue (6): 526-530.doi: 10.12047/j.cjap.5601.2017.125

超敏C反应蛋白与阵发性房颤射频消融术后早期复发的关系

赵月香¹, 单兆亮², 郭红阳², 林琨², 国建萍², 王玉堂¹

1. 解放军总医院南楼心血管内科, 北京 100853;
2. 解放军总医院心血管内科, 北京 100853

收稿日期:2017-04-10 修回日期:2017-10-14 出版日期:2017-11-28 发布日期:2018-06-19
基金资助:
军队保健专项课题（11BJZ10）

The relationship between high-sensitivity C-reactive protein (hsCRP) levels and atrial fibrillation early recurrence after paroxysmal atrial fibrillation radiofrequency catheter ablation

ZHAO Yue-xiang¹, SHAN Zhao-liang², GUO Hong-yang², LIN Kun², GUO Jian-ping², WANG Yu-tang¹

1. Department of Cardiology, Nanlou Clinal Division of PLA General Hospital, Beijing 100853, China;
2. Department of Cardiovascular Medicine of PLA General Hospital, Beijing 100853, China

Received:2017-04-10 Revised:2017-10-14 Online:2017-11-28 Published:2018-06-19
Contact: 王玉堂,Tel:010-66876291;E-mail:wvt301@sina.com E-mail:wvt301@sina.com
Supported by:
军队保健专项课题（11BJZ10）

摘要/Abstract

摘要： 目的：前瞻性研究超敏C反应蛋白（hsCRP）与阵发性心房颤动射频消融术后早期复发的关系。方法：接受CARTO指导房颤射频消融术的非瓣膜性阵发性房颤患者57例，平均年龄（53.32±9.98）岁，其中男42例，女15例。术前及术后5 d连续测定外周血hsCRP和高敏肌钙蛋白T （hs-cTnT）水平，记录体表心电图，行24 h动态心电图检查。术后5 d内，32名患者（56.14%）为窦性心律，为未复发组，25名（43.86%）复发房颤，为复发组。结果：未复发组与复发组患者的hsCRP与hs-cTnT日均升高量显著正相关，P=0.044，r=0.268。而两组间基线临床特征、手术前后血浆hsCRP、hs-cTnT水平、血浆hsCRP及hs-cTnT的总升高量（峰值水平-术前水平）、日均升高量（总升高量/达到峰值所用天数）无明显统计学差异（P均>0.05）。结论：房颤射频消融术后hsCRP升高变化与心肌损伤程度相关，与早期复发无直接关系，尚不能作为预测房颤术后早期复发的高危因子。

关键词: 心房颤动, 超敏C反应蛋白, 肺静脉隔离术, 早期复发

Abstract: Objective: To prospectively clarify the predictive value of high-sensitivity C-reactive protein (hsCRP) on the risk for recurrent atrial arrhythmia in paroxysmal atrial fibrillation (PAF) population who accepted radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF).Methods: There were 57 consecutive patients (53.32±9.98 years; 42 males) with drug-refractory PAF who underwent RFCA were included. Plasma levels of hsCRP and high-sensitivity cardiac troponin T (hs-cTnT) were measured on admission and first five days after RFCA. Twenty-five patients (43.86%) had early recurrence of atrial fibrillation (ERAF).Results: Compared to patients without ERAF (no-AF-recurrence group), baseline hsCRP levels had no significant difference in patients with ERAF (AF recurrence group). There were no significant differences in the peak hsCRP and hs-cTnT levels between no-AF-recurrence group and AF recurrence group. However, change of hsCRP level was significantly correlated with change in hs-cTnT level in patients undergoing RFCA (r=0.268, P=0.044).Conclusion: Among those AF patients undergoing ablation, change of hsCRP level could be for the myocardial injury related to RFCA procedure, which may not be a risk factor to predict ERAF. The variety of hsCRP level may be related to the degree of myocardial injury induced by RFCA.

Key words: atrial fibrillation, high-sensitivity C-reactive protein (hsCRP), circumferential pulmonary vein isolation (CPVI), early recurrence

赵月香, 单兆亮, 郭红阳, 林琨, 国建萍, 王玉堂. 超敏C反应蛋白与阵发性房颤射频消融术后早期复发的关系[J]. 中国应用生理学杂志, 2017, 33(6): 526-530.

ZHAO Yue-xiang, SHAN Zhao-liang, GUO Hong-yang, LIN Kun, GUO Jian-ping, WANG Yu-tang. The relationship between high-sensitivity C-reactive protein (hsCRP) levels and atrial fibrillation early recurrence after paroxysmal atrial fibrillation radiofrequency catheter ablation[J]. CJAP, 2017, 33(6): 526-530.

参考文献

[1] Kumagai K. Catheter ablation of atrial fibrillation. -State of the art-[J]. Circ J, 2011, 75(10):2305-2311.
[2] Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins:electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation[J]. Circulation, 1999, 100(18):1879-1886.
[3] Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation[J]. Circulation, 2005, 111(9):1100-1105.
[4] Yokokawa M, Tada H, Koyama K, et al. Thickening of the left atrial wall shortly after radiofrequency ablation predicts early recurrence of atrial fibrillation[J]. Circ J, 2010, 74(8):1538-1546.
[5] Lee SH, Tai CT, Hsieh MH, et al. Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol, 2004, 10(3):221-226.
[6] Koyama T, Sekiguchi Y, Tada H, et al. Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation[J]. Am J Cardiol, 2009, 103(9):1249-1254.
[7] Oral H, Knight BP, Ozaydin M, et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation[J]. J Am Coll Cardiol, 2002, 40(1):100-104.
[8] Marott SC, Nordestgaard BG, Zacho J, et al. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population[J]. J Am Coll Cardiol, 2010, 56(10):789-795.
[9] Fan J, Cao H, Su L, et al. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation[J]. J Interv Card Electrophysiol, 2012, 33(1):93-100.
[10] Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society[J]. Europace, 2007, 9(6):335-379.
[11] McCabe JM, Smith LM, Tseng ZH, et al. Protracted CRP elevation after atrial fibrillation ablation[J]. Pacing Clin Electrophysiol, 2008, 31(9):1146-1151.
[12] Wolbink GJ, Brouwer MC, Buysmann S, et al.CRP-mediated activation of complement in vivo:assessment by measuring circulating complement-CRP complexes[J]. J Immunol, 1996, 157(1):473-479.
[13] Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation, 1997, 96(10):3542-3548.
[14] Ellinor PT, Low A, Patton KK, et al. C-Reactive protein in lone atrial fibrillation[J]. Am J Cardiol, 2006, 97(9):1346-1350.
[15] Richter B, Gwechenberger M, Socas A, et al. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome[J]. Am J Cardiol, 2008, 101(6):843-847.
[16] Cai L, Yin Y, Ling Z, et al. Predictors of late recurrence of atrial fibrillation after catheter ablation[J]. Int J Cardiol, 2013, 164(1):82-87.
[17] Liu J, Fang PH, Dibs S, et al. High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation[J]. Pacing Clin Electrophysiol, 2011, 34(4):398-406.
[18] Masson S, Aleksova A, Favero C, et al. Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation:data from the GISSI atrial fibrillation trial[J]. Heart, 2010, 96(23):1909-1914.
[19] Lin YJ, Tsao HM, Chang SL, et al. The distance between the vein and lesions predicts the requirement of carina ablation in circumferential pulmonary vein isolation[J]. Europace, 2011, 13(3):376-382.
[20] Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy:C-reactive protein attenuates nitric oxide production and inhibits angiogenesis[J]. Circulation, 2002, 106(8):913-919.

超敏C反应蛋白与阵发性房颤射频消融术后早期复发的关系

The relationship between high-sensitivity C-reactive protein (hsCRP) levels and atrial fibrillation early recurrence after paroxysmal atrial fibrillation radiofrequency catheter ablation

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	王海军, 郭艳, 司全金, 王玉堂. 慢性肾功能不全对中老年非瓣膜性房颤患者全因死亡、心脑血管疾病死亡及血栓终点事件的影响[J]. 中国应用生理学杂志, 2018, 34(3): 209-215.
[2]	王海军, 史扬, 李健, 司全金, 王玉堂. 左房增大对起搏器术后的老年阵发性房颤患者再发房颤的影响[J]. 中国应用生理学杂志, 2017, 33(3): 257-261.
[3]	葛敏, 单锋, 唐碧, 侯秀杰. 二十二碳六烯酸对心房颤动大鼠心房肌生理改变及双孔钾通道TASK-1蛋白表达的影响[J]. 中国应用生理学杂志, 2016, 32(2): 128-131.